Monte Rosa stock falls as phase 2 prostate cancer study begins
Investing.com· Investing.com· Aug 24, 2026 · 2:52 PM
This is a summary. Read the complete story at Investing.com below.
Read full article at Investing.comRelated Stories
stocksabout 5 hours ago
J.B. Hunt stock plunges 10% after company warns third-quarter earnings will fall
Shares of J.B. Hunt plunged more than 10% Wednesday after the company warned of an earnings drop between 5% and 10%.
CNBC Stocks
stocksabout 5 hours ago
Why is CoreWeave stock climbing today?
Investing.com
stocksabout 5 hours ago
Sling Therapeutics raises $123m for thyroid eye disease drug trial
Investing.com